CHD4 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.45439216225896E-14 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
3.69939967548305E-10 |
Normal-vs-Stage2 |
1.44970002668998E-09 |
Normal-vs-Stage3 |
3.71258579434652E-13 |
Normal-vs-Stage4 |
1.05260000715646E-09 |
Stage1-vs-Stage2 |
2.371500E-02 |
Stage1-vs-Stage3 |
3.300600E-03 |
Stage1-vs-Stage4 |
4.560300E-02 |
Stage2-vs-Stage3 |
9.531400E-01 |
Stage2-vs-Stage4 |
6.798400E-01 |
Stage3-vs-Stage4 |
6.559600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.64512847788956E-12 |
Normal-vs-AfricanAmerican |
5.28049999948266E-07 |
Normal-vs-Asian |
6.490500E-02 |
Caucasian-vs-AfricanAmerican |
8.217400E-01 |
Caucasian-vs-Asian |
4.379200E-01 |
AfricanAmerican-vs-Asian |
5.294400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
9.99200722162641E-16 |
Normal-vs-Female |
8.84710005255585E-09 |
Male-vs-Female |
9.123300E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.97134999999626E-05 |
Normal-vs-Age(41-60Yrs) |
2.68289834792768E-11 |
Normal-vs-Age(61-80Yrs) |
2.24942287019303E-12 |
Normal-vs-Age(81-100Yrs) |
1.05289999996483E-06 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.614400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.492400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.657000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.366600E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.386770E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.072200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
2.496400E-01 |
Normal-vs-Grade 2 |
3.98370003651394E-10 |
Normal-vs-Grade 3 |
1.68454139526375E-12 |
Normal-vs-Grade 4 |
1.66989755356894E-11 |
Grade 1-vs-Grade 2 |
5.779600E-02 |
Grade 1-vs-Grade 3 |
7.959900E-03 |
Grade 1-vs-Grade 4 |
2.823000E-03 |
Grade 2-vs-Grade 3 |
3.755500E-02 |
Grade 2-vs-Grade 4 |
2.655800E-02 |
Grade 3-vs-Grade 4 |
4.842800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
3.67620045516048E-10 |
Normal-vs-ccB subtype |
1.4399037517876E-11 |
ccA subtype-vs-ccB subtype |
1.354950E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
3.01314528883267E-12 |
Normal-vs-N1 |
1.821380E-03 |
N0-vs-N1 |
8.715200E-01 |
|
|